基本情報
- CAS
390-28-3- 標準SMILES
COc1ccc(OC)c(C(O)C(C)N)c1- InChIKey
WJAJPNHVVFWKKL-UHFFFAOYSA-N- 分子式
- C11H17NO3
- 平均分子量
- 211.26 g/mol
- 単同位体質量
- 211.1208434
概要
Methoxamine is an amphetamine in which the parent 1-phenylpropan-2-amine skeleton is substituted at position 1 with an hydroxy group and the phenyl ring is 2- and 5-substituted with methoxy groups. It is an antihypotensive agent (pressor), an agonist acting directly at alpha-adrenoceptors with selectivity for the alpha-1 adrenoceptor subtype similar to phenylephrine. It has a role as an antihypotensive agent and an alpha-adrenergic agonist.
名称と識別子
- 優先名称
- Methoxamine
- IUPAC
- 2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol
- 現地名
- メトキサミン
- 英語名
- methoxamine
- 分子式
- C11H17NO3
- 分子量
- 211.26
名称と別名
名称をさらに表示
データベース識別子
- CAS
390-28-3- PubChem CID
- 6082
- DTXSID
DTXSID0023290- ChEMBL
CHEMBL524- ChEBI
CHEBI:6839- EC Number
- 206-867-3
- Nikkaji
- J5.717G
物性
構造計算による物性
- XLogP
- 0.5
- 極性表面積
- 64.7 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 4
- 回転可能結合数
- 4
- 重原子数
- 15
- 形式電荷
- 0
- 複雑度
- 189
実験および物理化学的性質
Solubility
Soluble (185 g/L)
9.21e+00 g/L
物理化学的性質
- 融点
- 85 · 85-86 °C
- 沸点
- 368.4 · 368.4±42.0 °C(Predicted)
- 比重(密度)
- 1.117 · 1.117±0.06 g/cm3(Predicted)
- 酸解離定数(Pka)
- 11.87 · 11.87±0.45(Predicted)
安全と法規制
毒性情報
Drug Induced Liver Injury
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
methoxamine
DILI Negative
Intramuscular; Intravenous
DOI:10.1016/j.drudis.2019.09.022
化学と産業
薬理情報
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
Pharmacodynamics
Methoxamine is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Methoxamine is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Methoxamine acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the heart's pumping action as well as constricting peripheral blood vessels.
MeSH Pharmacological Classification
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Drugs used to cause constriction of the blood vessels.
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS.
用途と製造
上流・下流製品情報
上流原料
サプライヤー14 社
関連反応
化合物ノート
読み込み中…